ReviewMicrobiologyOpen2026
Gastrointestinal Microbiome Dysbiosis in Cancer Development: Mechanisms and Biomarker Potential.
Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing evidence indicates that alterations in the gastrointestinal microbiota are associated with the initiation and progression of gastrointestinal cancers. Abundant evidence suggests that gastrointestinal microbiota dysbiosis plays an important role in the development of gastrointestinal cancers by producing proinflammatory and immunosuppressive signals. This review examines the role of microbiome dysbiosis in the pathogenesis of gastrointestinal malignancies. The composition of the microbiota varies greatly among individuals and depends on various factors such as age, diet, lifestyle, genetics, medications, and environmental factors. Given this diversity, a comprehensive characterization of the gastrointestinal microbiota is crucial to elucidate its role in carcinogenesis. Therefore, investigating the microbial composition of the host gastrointestinal tract can provide important information about the status of gastrointestinal cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.